CADTH is committed to supporting Canada’s health care decision-makers through this challenging and uncertain time.
For evidence, tools, and resources related to COVID-19, visit our COVID-19 Evidence Portal.

 

Begin main content

Sitaxsentan sodium

Last Updated: June 22, 2007
Result type: Reports
Project Number: S0099
Product Line: Reimbursement Review

Generic Name: Sitaxsentan sodium

Brand Name: Thelin

Manufacturer: Encysive Canada Inc.

Indications: Pulmonary arterial hypertension (WHO class II and III)

Submission Type: Initial

Project Status: Complete

Date Recommendation Issued: January 30, 2008

Recommendation Type: Do not list